x
|
Annual
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
|
o
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Texas
|
74-2211011
|
(State or other
jurisdiction of
|
(I.R.S.
Employer
|
incorporation or
organization)
|
Identification
Number)
|
Title of each
class
|
Name of each exchange on which
registered
|
Common Stock, par
value $0.10 per share
|
New York Stock
Exchange, Inc.
|
Preferred Stock
Purchase Rights
|
New York Stock
Exchange, Inc.
|
|
·
|
Maintain and Develop Close,
Long-Term Relationships with Customers. Our core strategy is to
maintain and establish long-term relationships with leading OEMs in
expanding industries by becoming an integral part of our customers’
manufacturing operations. To accomplish this, we work closely with our
customers throughout the design, manufacturing and distribution process,
and we offer flexible and responsive services. We rely on our local
management teams to respond to frequently changing customer design
specifications and production requirements, which develops stronger
customer relationships.
|
|
·
|
Focus on High-End Products in
Growth Industries. EMS providers produce products for a wide range
of OEMs in different industries, such as consumer electronics,
Internet-focused businesses and information technology equipment. The
product scope ranges from easy to assemble, low-cost high-volume products
targeted for the consumer market to complicated state-of-the-art, mission
critical electronic hardware targeted for military, medical and other
high-end computer use. Similarly, OEMs’ customers range from
consumer-oriented companies that compete primarily on price and redesign
their products every year to manufacturers of high-end telecommunications
equipment and computer and related products for business enterprises that
compete on technology and quality. We currently offer state-of-the-art
products for industry leaders who require specialized engineering design
and production services, as well as high volume manufacturing capabilities
to our customer base. Our ability to offer both of these types of services
enables us to expand our business
relationships.
|
|
·
|
Deliver Complete High and Low
Volume Manufacturing Solutions Globally. We believe OEMs are
increasingly requiring a wide range of specialized engineering and
manufacturing services from EMS providers in order to reduce costs and
accelerate their time-to-market and time-to-volume production. Building on
our integrated engineering and manufacturing capabilities, we offer
services from initial product design and test to final product assembly
and distribution to OEM customers. Our systems integration assembly and
direct order fulfillment services allow our customers to reduce product
cost and risk of product obsolescence by reducing their total
work-in-process and finished goods inventory. These services are available
at many of our manufacturing locations. In 2009, we added certain
precision machining assets and capabilities to provide precision
machining, metal joining and complex electro-mechanical manufacturing
services in Arizona, California and Mexico. We also offer our
customers high volume production in low cost regions of the world, such as
Brazil, China, Malaysia, Mexico, Romania and Thailand. These full service
capabilities allow us to offer customers the flexibility to move quickly
from design and initial product introduction to production and
distribution. We offer our customers the opportunity to combine the
benefits of low cost manufacturing (for the portions of their products or
systems that can benefit from the use of these geographic areas) with the
benefits and capabilities of our higher complexity support of systems
integration in Asia, Europe or the United
States.
|
|
·
|
Leverage Advanced
Technological Capabilities. In addition to traditional strengths in
manufacturing large, complex high-density printed circuit boards we offer
customers advanced design, technology and manufacturing solutions for
their primary products. We provide this engineering expertise through our
design capabilities in each of our facilities, and in our design centers.
We believe our capabilities help our customers improve product performance
and reduce costs.
|
|
·
|
Continue to Seek Cost Savings
and Efficiency Improvements. We seek to optimize our facilities to
provide cost-efficient services for our customers. We provide operations
in lower cost locations, including Brazil, China, Malaysia, Mexico,
Romania and Thailand, and we continue to expand our presence in these
lower cost locations to meet the needs of our
customers.
|
|
·
|
Continue Our Global Expansion.
A network of strategically positioned facilities can reduce costs,
simplify and shorten an OEM’s supply chain and thus reduce the time it
takes to bring product to market. We are committed to geographic expansion
in order to support our customers with cost-effective and timely delivery
of quality products and services worldwide. Our acquisition of facilities
in Malaysia, Romania and the Netherlands has expanded our service scope to
provide a global manufacturing solution to our customers through our 24
facilities in ten countries located in Brazil, China, Ireland, Malaysia,
Mexico, the Netherlands, Romania, Singapore, Thailand and the United
States.
|
|
·
|
Pursue Strategic
Acquisitions. Our capabilities have continued to grow through
acquisitions and we will continue to selectively seek acquisition
opportunities. Our acquisitions have enhanced our business in the
following ways:
|
|
-
|
expanded
geographic presence;
|
|
-
|
enhanced
customer growth opportunities;
|
|
-
|
developed
strategic relationships;
|
|
-
|
broadened
service offerings;
|
|
-
|
diversified
into new market sectors; and
|
|
-
|
added
experienced management teams.
|
|
·
|
New Product Design, Prototype,
Test and Related Engineering
Solutions. We offer a full spectrum of new product design,
prototype, test and related engineering solutions. Our concurrent
engineering approach shortens product development cycles and gives our
customers a competitive advantage in time-to-market and time-to-profit.
Our multi-disciplined engineering teams provide expertise in a number of
core competencies critical to serving OEMs in our target markets,
including award-winning industrial design, mechanical and electrical
hardware, firmware, software and systems integration and support. We
create specifications, designs and quick-turn prototypes, and validate and
ramp our customers’ products into high volume
manufacturing.
|
|
·
|
Custom Test and Automation Equipment Design
and Build
Solutions. We provide our customers with a comprehensive range of
custom automated test equipment, functional test equipment, process
automation and replication solutions. We have expertise in tooling,
testers, equipment control, systems planning, automation, floor control,
systems integration, replication and programming. Our custom functional
test equipment, process automation and replication solutions are available
to our customers as part of our full service product design and
manufacturing solutions package or on a stand-alone basis for products
designed and manufactured elsewhere. We also provide custom test equipment
and automation system solutions to OEMs. Our ability to provide these
solutions allows us to capitalize on OEMs’ increasing needs for custom
manufacturing solutions and provides an additional opportunity for us to
introduce these customers to our comprehensive engineering and
manufacturing services.
|
|
·
|
Printed Circuit Board
Assembly & Test. We offer a
wide range of printed circuit board assembly and test solutions, including
printed circuit board assembly, assembly of subsystems, circuitry and
functionality testing of printed assemblies, environmental and stress
testing and component reliability
testing.
|
|
·
|
Flex Circuit Assembly & Test. We provide
our customers with a wide range of flex circuit assembly and test
solutions. We utilize specialized tooling strategies and advanced
automation procedures to minimize circuit handling and ensure that
consistent processing parameters are maintained throughout the assembly
process.
|
|
·
|
Systems Assembly & Test. We work with our
customers to develop product-specific test strategies. Our test
capabilities include manufacturing defect analysis, in-circuit tests to
test the circuitry of the board and functional tests to confirm that the
board or assembly operates in accordance with its final design and
manufacturing specifications. We either custom design test equipment and
software ourselves or use test equipment and software provided by our
customers. In addition, we provide environmental stress tests of
assemblies of boards or systems.
|
|
·
|
Pin
Thru Hole;
|
|
·
|
Surface
Mount Technology;
|
|
·
|
Fine
Pitch;
|
|
·
|
Ball
Grid Array;
|
|
·
|
Flip
Chip;
|
|
·
|
Chip
On Board/Wire bonding;
|
|
·
|
In-Circuit
Test;
|
|
·
|
Board
Level Functional Test; and
|
|
·
|
Stress
Testing.
|
|
·
|
Adhesives;
|
|
·
|
Conformal
Coating;
|
|
·
|
Laser
Welding;
|
|
·
|
Hybrid
Optical/Electrical Printed Circuit Board Assembly and Test;
and
|
|
·
|
Sub-micron
Alignment of Optical
Sub-Assemblies.
|
|
·
|
Complex
Small / Medium / Large Computer Numerical Controlled
Machining;
|
|
·
|
Precision
Multi-Axis Grinding of Aerospace Engine Blades, Vanes and
Nozzles;
|
|
·
|
Precision
Grinding of Mass Spectrometer
Components;
|
|
·
|
Sinker
Electrical Discharge Machining;
|
|
·
|
Turnkey
Precision Clean Room Module Assembly and Functional Test;
and
|
|
·
|
Major
Electro-Mechanical Sub Assembly.
|
2009
|
2008
|
2007
|
||||||||||
Computers
and related products for business enterprises
|
39 | % | 48 | % | 53 | % | ||||||
Telecommunication
equipment
|
23 | 18 | 15 | |||||||||
Industrial
control equipment
|
20 | 16 | 13 | |||||||||
Medical
devices
|
14 | 14 | 13 | |||||||||
Testing
and instrumentation products
|
4 | 4 | 6 |
|
·
|
computers
and related products for business
enterprises;
|
|
·
|
medical
devices;
|
|
·
|
industrial
control equipment;
|
|
·
|
testing
and instrumentation products; and
|
|
·
|
telecommunication
equipment.
|
|
·
|
variation
in demand for our customers’
products;
|
|
·
|
our
customers’ attempts to manage their
inventory;
|
|
·
|
electronic
design changes;
|
|
·
|
changes
in our customers’ manufacturing strategy;
and
|
|
·
|
acquisitions
of or consolidations among
customers.
|
|
·
|
difficulties
in staffing and managing foreign
operations;
|
|
·
|
political
and economic instability (including acts of terrorism and outbreaks of
war), which could impact our ability to ship and/or receive
product;
|
|
·
|
unexpected
changes in regulatory requirements and
laws;
|
|
·
|
longer
customer payment cycles and difficulty collecting accounts
receivable;
|
|
·
|
export
duties, import controls and trade barriers (including
quotas);
|
|
·
|
governmental
restrictions on the transfer of
funds;
|
|
·
|
burdens
of complying with a wide variety of foreign laws and labor
practices;
|
|
·
|
fluctuations
in currency exchange rates, which could affect component costs, local
payroll, utility and other expenses;
and
|
|
·
|
inability
to utilize net operating losses incurred by our foreign operations to
reduce our U.S. income taxes.
|
|
·
|
integration
and management of the operations;
|
|
·
|
retention
of key personnel;
|
|
·
|
integration
of purchasing operations and information
systems;
|
|
·
|
retention
of the customer base of acquired
businesses;
|
|
·
|
management
of an increasingly larger and more geographically disparate business;
and
|
|
·
|
diversion
of management’s attention from other ongoing business
concerns.
|
|
·
|
the
volume of customer orders relative to our
capacity;
|
|
·
|
customer
introduction and market acceptance of new
products;
|
|
·
|
changes
in demand for customer products;
|
|
·
|
pricing
and other competitive pressures;
|
|
·
|
the
timing of our expenditures in anticipation of future
orders;
|
|
·
|
our
effectiveness in managing manufacturing
processes;
|
|
·
|
changes
in cost and availability of labor and
components;
|
|
·
|
changes
in our product mix;
|
|
·
|
changes
in political and economic conditions;
and
|
|
·
|
local
factors and events that may affect our production volume, such as local
holidays.
|
|
·
|
a
“poison pill” shareholder rights
plan;
|
|
·
|
a
statutory restriction on the ability of shareholders to take action by
less than unanimous written consent;
and
|
|
·
|
a
statutory restriction on business combinations with some types of
interested shareholders.
|
Location
|
Sq.
Ft.
|
Ownership
|
|||
Almelo,
the Netherlands
|
132,000 |
Leased
|
|||
Angleton,
Texas
|
109,000 |
Owned
|
|||
Austin,
Texas
|
93,000 |
Leased
|
|||
Ayudhaya,
Thailand
|
243,000 |
Owned
|
|||
Ayudhaya,
Thailand
|
180,000 |
Owned
|
|||
Beaverton,
Oregon
|
77,000 |
Leased
|
|||
Brasov,
Romania
|
108,000 |
Leased
|
|||
Campinas,
Brazil
|
40,000 |
Leased
|
|||
Concord,
California
|
80,000 |
Leased
|
|||
Dublin,
Ireland
|
46,000 |
Leased
|
|||
Dunseith,
North Dakota
|
47,000 |
Owned
|
|||
Dunseith,
North Dakota
|
53,000 |
Leased
|
|||
Freemont,
California
|
52,000 |
Leased
|
|||
Guadalajara,
Mexico
|
150,000 |
Leased
|
|||
Guaymas,
Mexico
|
52,000 |
Leased
|
|||
Hudson,
New Hampshire
|
170,000 |
Leased
|
|||
Huntsville,
Alabama
|
276,000 |
Owned
|
|||
Huntsville,
Alabama
|
144,000 |
Leased
|
|||
Korat,
Thailand
|
126,000 |
Owned
|
|||
Penang,
Malaysia
|
103,000 |
Owned
|
|||
Rochester,
Minnesota
|
260,000 |
Leased
|
|||
Suzhou,
China
|
250,000 |
Owned
|
|||
Singapore
|
48,000 |
Leased
|
|||
Tempe,
Arizona
|
48,000 |
Leased
|
|||
Winona,
Minnesota
|
199,000 |
Owned
|
|||
Total
|
3,086,000 | ||||
High
|
Low
|
|||||||
2010
|
||||||||
First quarter (through February
25, 2010)
|
$ | 20.68 | $ | 17.67 | ||||
2009
|
||||||||
Fourth
quarter
|
$ | 19.81 | $ | 16.42 | ||||
Third
quarter
|
$ | 18.34 | $ | 13.42 | ||||
Second
quarter
|
$ | 14.98 | $ | 10.77 | ||||
First
quarter
|
$ | 13.60 | $ | 8.60 | ||||
2008
|
||||||||
Fourth
quarter
|
$ | 14.36 | $ | 8.75 | ||||
Third
quarter
|
$ | 19.11 | $ | 13.88 | ||||
Second
quarter
|
$ | 18.97 | $ | 16.22 | ||||
First
quarter
|
$ | 19.98 | $ | 14.90 |
(d)
Maximum
|
|||||||||||||
(c)
Total
|
Number
(or
|
||||||||||||
Number
of
|
Approximate
|
||||||||||||
Shares
(or
|
Dollar
Value)
|
||||||||||||
Units)
|
of
Shares (or
|
||||||||||||
Purchased
as
|
Units)
that
|
||||||||||||
(a)
Total
|
Part
of
|
May
Yet Be
|
|||||||||||
Number
of
|
(b)
Average
|
Publicly
|
Purchased
|
||||||||||
Shares
(or
|
Price
Paid per
|
Announced
|
Under
the
|
||||||||||
Units)
|
Share
(or
|
Plans
or
|
Plans
or
|
||||||||||
Purchased
(1)
|
Unit)
(2)
|
Programs
|
Programs
(3)
|
||||||||||
October
1 to 31, 2009
|
330,000 | $ | 18.00 | 330,000 |
62.2
million
|
||||||||
November
1 to 30, 2009
|
317,533 | $ | 17.91 | 317,533 |
56.5
million
|
||||||||
December
1 to 31, 2009
|
330,000 | $ | 18.91 | 330,000 |
50.3
million
|
||||||||
Total
|
977,533 | $ | 18.28 | 977,533 |
Dec-04
|
Dec-05
|
Dec-06
|
Dec-07
|
Dec-08
|
Dec-09
|
|||||||||||||||||||
Benchmark
Electronics, Inc.
|
$ | 100.00 | $ | 98.60 | $ | 107.20 | $ | 78.00 | $ | 56.20 | $ | 83.20 | ||||||||||||
Peer
Group
|
$ | 100.00 | $ | 89.30 | $ | 77.80 | $ | 66.90 | $ | 22.30 | $ | 56.40 | ||||||||||||
S&P
500
|
$ | 100.00 | $ | 103.00 | $ | 117.00 | $ | 121.20 | $ | 74.50 | $ | 92.00 |
Year
Ended December 31,
|
||||||||||||||||||||
(in
thousands, except per share data)
|
2009
|
2008
|
2007
|
2006
|
2005
|
|||||||||||||||
Selected
Statements of Income (Loss) Data
|
||||||||||||||||||||
Sales
|
$ | 2,089,253 | $ | 2,590,167 | $ | 2,915,919 | $ | 2,907,304 | $ | 2,257,225 | ||||||||||
Cost
of sales
|
1,942,674 | 2,414,231 | 2,717,425 | 2,708,144 | 2,095,623 | |||||||||||||||
Gross
profit
|
146,579 | 175,936 | 198,494 | 199,160 | 161,602 | |||||||||||||||
Selling,
general and administrative
|
||||||||||||||||||||
expenses
|
85,500 | 92,154 | 96,614 | 70,109 | 62,322 | |||||||||||||||
Restructuring
charges and
|
||||||||||||||||||||
integration costs (1)
|
8,264 | 2,780 | 11,581 | 4,723 | — | |||||||||||||||
Goodwill
impairment (2)
|
— | 247,482 | — | — | — | |||||||||||||||
Income
(loss) from operations
|
52,815 | (166,480 | ) | 90,299 | 124,328 | 99,280 | ||||||||||||||
Interest
expense
|
(1,399 | ) | (1,455 | ) | (2,183 | ) | (354 | ) | (330 | ) | ||||||||||
Interest
income
|
2,210 | 8,675 | 11,217 | 8,824 | 7,786 | |||||||||||||||
Other
income (expense)
|
(1,705 | ) | 1,772 | 693 | (2,214 | ) | (922 | ) | ||||||||||||
Income
tax benefit (expense) (3)
|
1,974 | 21,856 | (7,670 | ) | (19,762 | ) | (25,225 | ) | ||||||||||||
Net income
(loss)
|
$ | 53,895 | $ | (135,632 | ) | $ | 92,356 | $ | 110,822 | $ | 80,589 | |||||||||
Earnings
(loss) per share: (4)
|
||||||||||||||||||||
Basic
|
$ | 0.83 | $ | (2.02 | ) | $ | 1.28 | $ | 1.72 | $ | 1.29 | |||||||||
Diluted
|
$ | 0.83 | $ | (2.02 | ) | $ | 1.27 | $ | 1.70 | $ | 1.25 | |||||||||
Weighted-average
number of
|
||||||||||||||||||||
shares
outstanding:
|
||||||||||||||||||||
Basic
|
64,758 | 67,060 | 72,061 | 64,306 | 62,682 | |||||||||||||||
Diluted
|
65,116 | 67,060 | 72,829 | 65,121 | 64,279 | |||||||||||||||
December
31,
|
||||||||||||||||||||
(in
thousands)
|
2009
|
2008(5)
|
2007(5)
|
2006(5)
|
2005(5)
|
|||||||||||||||
Selected
Balance Sheet Data
|
||||||||||||||||||||
Working
capital (5)
|
$ | 859,095 | $ | 813,876 | $ | 879,263 | $ | 755,011 | $ | 640,482 | ||||||||||
Total
assets (5)
|
1,465,720 | 1,433,040 | 1,756,967 | 1,400,239 | 1,292,527 | |||||||||||||||
Total
debt
|
11,681 | 11,939 | 12,526 | — | — | |||||||||||||||
Shareholders’
equity (5)
|
$ | 1,090,903 | $ | 1,050,574 | $ | 1,283,367 | $ | 979,459 | $ | 840,238 |
(1)
|
See
Note 16 to the Consolidated Financial Statements for a discussion of the
restructuring charges and integration costs occurring in 2009, 2008 and
2007. During 2006, the Company recognized restructuring charges totaling
$4.7 million related to reductions in workforce and the resizing and
closure of certain facilities.
|
(2)
|
During
the fourth quarter of 2008, the Company recorded a non-cash goodwill
impairment charge totaling $247.5 million. See Note 1(i) to the
Consolidated Financial Statements for a discussion of the impairment
charge.
|
(3)
|
During
the third quarter of 2009, the Company recorded a $2.7 million discrete
tax benefit related to a previously closed facility, a $2.4 million tax
benefit related to a revaluation loss in Mexico and a $1.2 million tax
benefit related to intercompany pricing deductions. During the third
quarter of 2008, the Company recorded a $3.4 million discrete tax benefit
related to a previously closed facility. During the third quarter of 2007,
the Company recorded a $6.5 million discrete tax benefit related to a
previously closed facility. During the first quarter of 2006, the Company
recorded a $4.8 million tax benefit for the write-off of the investment in
the Leicester, England subsidiary.
|
(4)
|
See
Note 1(j) to the Consolidated Financial Statements for the basis of
computing earnings (loss) per
share.
|
(5)
|
See
Note 1(r) to the Consolidated Financial Statements for a discussion of the
correction of an immaterial error related to deferred income
taxes.
|
Year
ended December 31,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Sales
|
100.0 | % | 100.0 | % | 100.0 | % | ||||||
Cost
of sales
|
93.0 | 93.2 | 93.2 | |||||||||
Gross
profit
|
7.0 | 6.8 | 6.8 | |||||||||
Selling,
general and administrative expenses
|
4.1 | 3.6 | 3.3 | |||||||||
Restructuring
charges and integration costs
|
0.4 | 0.1 | 0.4 | |||||||||
Goodwill
impairment
|
— | 9.6 | — | |||||||||
Income
(loss) from operations
|
2.5 | (6.4 | ) | 3.1 | ||||||||
Other
income, net
|
(0.0 | ) | 0.3 | 0.3 | ||||||||
Income (loss) before income
taxes
|
2.5 | (6.1 | ) | 3.4 | ||||||||
Income
tax benefit (expense)
|
0.1 | 0.8 | (0.3 | ) | ||||||||
Net income
(loss)
|
2.6 | % | (5.2 | )% | 3.2 | % |
2009
|
2008
|
|||||||
Computers
and related products for business enterprises
|
39 | % | 48 | % | ||||
Telecommunication
equipment
|
23 | 18 | ||||||
Industrial
control equipment
|
20 | 16 | ||||||
Medical
devices
|
14 | 14 | ||||||
Testing
and instrumentation products
|
4 | 4 | ||||||
100 | % | 100 | % |
2008
|
2007
|
|||||||
Computers
and related products for business enterprises
|
48 | % | 53 | % | ||||
Telecommunication
equipment
|
18 | 15 | ||||||
Industrial
control equipment
|
16 | 13 | ||||||
Medical
devices
|
14 | 13 | ||||||
Testing
and instrumentation products
|
4 | 6 | ||||||
100 | % | 100 | % |
Payments
due by period
|
||||||||||||||||||||
Less
than
|
1-3
|
3-5
|
More
than
|
|||||||||||||||||
(in
thousands)
|
Total
|
1
year
|
years
|
years
|
5
years
|
|||||||||||||||
Operating
lease obligations
|
$ | 47,309 | $ | 12,210 | $ | 19,333 | $ | 8,622 | $ | 7,144 | ||||||||||
Capital
lease obligations
|
21,928 | 1,469 | 3,019 | 3,131 | 14,309 | |||||||||||||||
Total
obligations
|
$ | 69,237 | $ | 13,679 | $ | 22,352 | $ | 11,753 | $ | 21,453 |
|
•
|
Foreign
currency exchange risk;
|
|
•
|
Import
and export duties, taxes and regulatory
changes;
|
|
•
|
Inflationary
economies or currencies; and
|
|
•
|
Economic
and political instability.
|
December
31,
|
||||||||
(in
thousands, except for par value)
|
2009
|
2008
|
||||||
Assets
|
||||||||
Current
assets:
|
||||||||
Cash and cash
equivalents
|
$ | 421,243 | $ | 359,694 | ||||
Accounts receivable, net of
allowance for doubtful accounts of $417
|
||||||||
and $1,072,
respectively
|
417,268 | 422,058 | ||||||
Inventories,
net
|
315,743 | 343,163 | ||||||
Prepaid expenses and other
assets
|
31,034 | 28,308 | ||||||
Income taxes
receivable
|
3,526 | — | ||||||
Deferred income
taxes
|
9,861 | 2,184 | ||||||
Total current
assets
|
1,198,675 | 1,155,407 | ||||||
Long-term
investments
|
45,686 | 48,162 | ||||||
Property, plant and equipment,
net
|
126,250 | 134,618 | ||||||
Goodwill,
net
|
37,912 | 37,912 | ||||||
Deferred income
taxes
|
17,713 | 24,317 | ||||||
Other, net
|
39,484 | 32,624 | ||||||
$ | 1,465,720 | $ | 1,433,040 | |||||
Liabilities
and Shareholders’ Equity
|
||||||||
Current
liabilities:
|
||||||||
Current installments of capital
lease obligations
|
$ | 300 | $ | 256 | ||||
Accounts
payable
|
275,900 | 288,045 | ||||||
Income taxes
payable
|
6,464 | 3,745 | ||||||
Accrued
liabilities
|
56,916 | 49,485 | ||||||
Total current
liabilities
|
339,580 | 341,531 | ||||||
Capital lease obligations, less
current installments
|
11,381 | 11,683 | ||||||
Other long-term
liabilities
|
23,856 | 29,252 | ||||||
Shareholders’
equity:
|
||||||||
Preferred shares, $0.10 par
value; 5,000 shares authorized, none issued
|
— | — | ||||||
Common shares, $0.10 par value;
145,000 shares authorized;
|
||||||||
issued – 64,208 and 65,337,
respectively;
|
||||||||
outstanding – 64,097 and 65,226
respectively
|
6,410 | 6,523 | ||||||
Additional paid-in
capital
|
732,956 | 741,813 | ||||||
Retained
earnings
|
356,802 | 312,695 | ||||||
Accumulated other comprehensive
loss
|
(4,993 | ) | (10,185 | ) | ||||
Less treasury shares, at cost;
111 shares
|
(272 | ) | (272 | ) | ||||
Total shareholders’
equity
|
1,090,903 | 1,050,574 | ||||||
Commitments and
contingencies
|
||||||||
$ | 1,465,720 | $ | 1,433,040 |
Year
ended December 31,
|
||||||||||||
(in
thousands, except per share data)
|
2009
|
2008
|
2007
|
|||||||||
Sales
|
$ | 2,089,253 | $ | 2,590,167 | $ | 2,915,919 | ||||||
Cost
of sales
|
1,942,674 | 2,414,231 | 2,717,425 | |||||||||
Gross
profit
|
146,579 | 175,936 | 198,494 | |||||||||
Selling,
general and administrative expenses
|
85,500 | 92,154 | 96,614 | |||||||||
Restructuring
charges and integration costs
|
8,264 | 2,780 | 11,581 | |||||||||
Goodwill
impairment
|
— | 247,482 | — | |||||||||
Income
(loss) from operations
|
52,815 | (166,480 | ) | 90,299 | ||||||||
Interest
expense
|
(1,399 | ) | (1,455 | ) | (2,183 | ) | ||||||
Interest
income
|
2,210 | 8,675 | 11,217 | |||||||||
Other
income (expense)
|
(1,705 | ) | 1,772 | 693 | ||||||||
Income
(loss) before income taxes
|
51,921 | (157,488 | ) | 100,026 | ||||||||
Income
tax benefit (expense)
|
1,974 | 21,856 | (7,670 | ) | ||||||||
Net income
(loss)
|
$ | 53,895 | $ | (135,632 | ) | $ | 92,356 | |||||
Earnings
(loss) per share:
|
||||||||||||
Basic
|
$ | 0.83 | $ | (2.02 | ) | $ | 1.28 | |||||
Diluted
|
$ | 0.83 | $ | (2.02 | ) | $ | 1.27 | |||||
Weighted-average
number of shares outstanding:
|
||||||||||||
Basic
|
64,758 | 67,060 | 72,061 | |||||||||
Diluted
|
65,116 | 67,060 | 72,829 |
Year
ended December 31,
|
||||||||||||
(in
thousands)
|
2009
|
2008
|
2007
|
|||||||||
Net
income (loss)
|
$ | 53,895 | $ | (135,632 | ) | $ | 92,356 | |||||
Other
comprehensive income (loss):
|
||||||||||||
Foreign currency translation
adjustments
|
4,393 | (6,462 | ) | 8,019 | ||||||||
Unrealized gain (loss) on
investments, net of tax
|
924 | (5,313 | ) | — | ||||||||
Other
|
(125 | ) | (26 | ) | 76 | |||||||
Comprehensive
income (loss)
|
$ | 59,087 | $ | (147,433 | ) | $ | 100,451 |
December
31,
|
||||||||
(in
thousands)
|
2009
|
2008
|
||||||
Foreign
currency translation losses
|
$ | (453 | ) | $ | (4,846 | ) | ||
Unrealized
loss on investments, net of tax
|
(4,389 | ) | (5,313 | ) | ||||
Other
|
(151 | ) | (26 | ) | ||||
$ | (4,993 | ) | $ | (10,185 | ) |
(in
thousands)
|
Shares
|
Common
Shares
|
Additional
paid-in
capital
|
Retained
earnings
|
Accumulated
other comprehensiveincome
(loss)
|
Treasury
shares
|
Total shareholders’ |
|||||||||||||||||||||
Balances,
December 31, 2006
|
64,751 | $ | 6,475 | $ | 587,522 | $ | 392,213 | $ | (6,479 | ) | $ | (272 | ) | $ | 979,459 | |||||||||||||
Adjustment
from adoption of
|
||||||||||||||||||||||||||||
new income tax
standard
|
— | — | — | 19,335 | — | — | 19,335 | |||||||||||||||||||||
Stock-based
compensation expense
|
— | — | 4,454 | — | — | — | 4,454 | |||||||||||||||||||||
Merger
|
7,302 | 730 | 215,240 | — | — | — | 215,970 | |||||||||||||||||||||
Conversion
of debt
|
351 | 35 | 4,965 | — | — | — | 5,000 | |||||||||||||||||||||
Shares
repurchased and retired
|
(2,602 | ) | (260 | ) | (27,991 | ) | (24,718 | ) | — | — | (52,969 | ) | ||||||||||||||||
Stock
options exercised
|
774 | 78 | 9,134 | — | — | — | 9,212 | |||||||||||||||||||||
Federal
tax benefit of
|
||||||||||||||||||||||||||||
stock options
exercised
|
— | — | 2,455 | — | — | — | 2,455 | |||||||||||||||||||||
Comprehensive
income
|
— | — | — | 92,356 | 8,095 | — | 100,451 | |||||||||||||||||||||
Balances,
December 31, 2007
|
70,576 | 7,058 | 795,779 | 479,186 | 1,616 | (272 | ) | 1,283,367 | ||||||||||||||||||||
Stock-based
compensation expense
|
— | — | 4,732 | — | — | — | 4,732 | |||||||||||||||||||||
Shares
repurchased and retired
|
(5,802 | ) | (580 | ) | (62,394 | ) | (30,859 | ) | — | — | (93,833 | ) | ||||||||||||||||
Stock
options exercised
|
312 | 31 | 2,902 | — | — | — | 2,933 | |||||||||||||||||||||
Issuance
of restricted shares
|
140 | 14 | (14 | ) | — | — | — | — | ||||||||||||||||||||
Federal
tax benefit of
|
||||||||||||||||||||||||||||
stock options
exercised
|
— | — | 808 | — | — | — | 808 | |||||||||||||||||||||
Comprehensive
loss
|
— | — | — | (135,632 | ) | (11,801 | ) | — | (147,433 | ) | ||||||||||||||||||
Balances,
December 31, 2008
|
65,226 | 6,523 | 741,813 | 312,695 | (10,185 | ) | (272 | ) | 1,050,574 | |||||||||||||||||||
Stock-based
compensation expense
|
— | — | 5,356 | — | — | — | 5,356 | |||||||||||||||||||||
Shares
repurchased and retired
|
(1,672 | ) | (167 | ) | (17,964 | ) | (9,788 | ) | — | — | (27,919 | ) | ||||||||||||||||
Stock
options exercised
|
366 | 36 | 3,566 | — | — | — | 3,602 | |||||||||||||||||||||
Issuance
of restricted shares
|
150 | 15 | (15 | ) | — | — | — | — | ||||||||||||||||||||